These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6324668)

  • 1. Relation between aminoglycoside 2"-O-nucleotidyltransferase activity and aminoglycoside resistance.
    Bongaerts GP; Molendijk L
    Antimicrob Agents Chemother; 1984 Feb; 25(2):234-7. PubMed ID: 6324668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
    Jacoby GA; Blaser MJ; Santanam P; Hächler H; Kayser FH; Hare RS; Miller GH
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2381-6. PubMed ID: 1965106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of aminoglycoside resistance with the KmS and Vmax/Km ratios of enzymatic modification of aminoglycosides by 2''-O-nucleotidyltransferase.
    DeHertogh DA; Lerner SA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):670-1. PubMed ID: 2988434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANT(4')I: a new aminoglycoside nucleotidyltransferase found in "staphylococcus aureus" (author's transl)].
    Le Goffic F; Baca B; Soussy CJ; Dublanchet A; Duval J
    Ann Microbiol (Paris); 1976 Apr; 127(3):391-9. PubMed ID: 1047990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANT(9)-Ic, a Novel Chromosomally Encoded Aminoglycoside Nucleotidyltransferase from Brucella intermedia.
    Sheng X; Lu W; Li A; Lu J; Song C; Xu J; Dong Y; Fu C; Lin X; Zhu M; Bao Q; Li K
    Microbiol Spectr; 2023 Jun; 11(3):e0062023. PubMed ID: 37039640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of antibiotic resistance with Vmax/Km ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase.
    Radika K; Northrop DB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):479-82. PubMed ID: 6375556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci.
    Carlier C; Courvalin P
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1565-9. PubMed ID: 2171424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.
    Hirsch DR; Cox G; D'Erasmo MP; Shakya T; Meck C; Mohd N; Wright GD; Murelli RP
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4943-7. PubMed ID: 25283553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
    Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
    Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial resistance to aminoglycoside antibiotics].
    Kettner M; Macicková T
    Bratisl Lek Listy; 1992 Apr; 93(4):175-8. PubMed ID: 1393633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics.
    Eyckmans L; Beert J
    Infection; 1977; 5(1):9-12. PubMed ID: 404254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the Catalytic Cycle and Kinetic Mechanism of Aminoglycoside
    Bassenden AV; Park J; Rodionov D; Berghuis AM
    ACS Chem Biol; 2020 Mar; 15(3):686-694. PubMed ID: 32100995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to apramycin in Escherichia coli isolated from animals: detection of a novel aminoglycoside-modifying enzyme.
    Hedges RW; Shannon KP
    J Gen Microbiol; 1984 Mar; 130(3):473-82. PubMed ID: 6374024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.